Neurochlore
Marseille
About Neurochlore
Neurochlore to develop and test novel applications for its therapeutic agent. Indeed, Neurochlore has an international patent in the use of a diuretic in the treatment of autism spectrum disorders and another syndrome associated with autism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Non-Equity Assistance (Apr 2011)
- Website: neurochlore.fr
- Phone: +33 4 84 26 90 60
Industries & Categories
Clinical Trials, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurochlore-2833133 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.